{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:59:45Z","timestamp":1778864385561,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T00:00:00Z","timestamp":1540771200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Syst Biol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12918-018-0606-6","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T15:27:15Z","timestamp":1540826835000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The anticancer mechanism investigation of Tanshinone IIA by pharmacological clustering in protein network"],"prefix":"10.1186","volume":"12","author":[{"given":"Yan-feng","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-jiang","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,29]]},"reference":[{"key":"606_CR1","first-page":"44","volume":"1","author":"D Wang","year":"1993","unstructured":"Wang D, Wang L. Study on the anti-cancer effects of Huoxue Huayu Chinese herbs. Jilin J Tradit Chin Med. 1993;1:44\u20135.","journal-title":"Jilin J Tradit Chin Med"},{"key":"606_CR2","unstructured":"Lin M. Contribution of Shennong's Classic of Materia Medica on the development of Anti-cancer Chinese medicinal products [D]. Guang Zhou University of Chinese Medicine; 2011. Chinese."},{"issue":"13","key":"606_CR3","first-page":"356","volume":"19","author":"W Qing-lin","year":"2013","unstructured":"Qing-lin W, Li X. Law research on Chinese medicine with prescription anti-cancer proprietary. Chin J Exp Tradit Med Formula. 2013;19(13):356\u20139.","journal-title":"Chin J Exp Tradit Med Formula"},{"issue":"27","key":"606_CR4","first-page":"182","volume":"23","author":"J Liao","year":"2017","unstructured":"Liao J, Zhao M, Li Y. A review on pharmacological actions of Danshen. Contemp Med. 2017;23(27):182\u20134.","journal-title":"Contemp Med"},{"issue":"4","key":"606_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s11655-016-2272-0","volume":"23","author":"J Wu","year":"2017","unstructured":"Wu J, Liu S, Zhang X, Zhang B. Danshen injection as adjuvant treatment for unstable angina Pectoris\u00a0: a systematic review and meta-analysis. Chin J Integr Med. 2017;23(4):306\u201311. https:\/\/doi.org\/10.1007\/s11655-016-2272-0 .","journal-title":"Chin J Integr Med"},{"issue":"4","key":"606_CR6","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/med","volume":"161","author":"X Chen","year":"2013","unstructured":"Chen X, Guo J, Bao J, Lu J, Wang Y. The anticancer properties of Salvia Miltiorrhiza Bunge ( Danshen ): a systematic review. Med Res Rev. 2013;161(4):768\u201394. https:\/\/doi.org\/10.1002\/med .","journal-title":"Med Res Rev"},{"key":"606_CR7","doi-asserted-by":"crossref","unstructured":"Bae W, Choi J, Kim K, Syn HU. Inhibition of proliferation of prostate cancer cell line DU-145 in vitro and in vivo using Salvia miltiorrhiza Bunge. Chin J Integr Med. 2017; Epub ahead.","DOI":"10.1007\/s11655-017-2801-5"},{"issue":"53","key":"606_CR8","doi-asserted-by":"crossref","first-page":"90925","DOI":"10.18632\/oncotarget.18767","volume":"8","author":"C Wu","year":"2017","unstructured":"Wu C, Cherng J, Yang Y, Lin C. Danshen improves survival of patients with advanced lung cancer and targeting the relationship between macrophages and lung cancer cells. Oncotarget. 2017;8(53):90925\u201347.","journal-title":"Oncotarget"},{"key":"606_CR9","unstructured":"Kaptchuk TJ. Chinese Medicine: The Web That Has No Weaver. 2nd ed. New York: Rider; 2000."},{"issue":"2","key":"606_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S1674-6384(16)60018-7","volume":"8","author":"Y-Q Zhang","year":"2016","unstructured":"Zhang Y-Q, Mao X, Guo Q-Y, Lin N, Li S. Network pharmacology-based approaches capture essence of Chinese herbal medicines. Chinese Herb Med. 2016;8(2):107\u201316. https:\/\/doi.org\/10.1016\/S1674-6384(16)60018-7 .","journal-title":"Chinese Herb Med"},{"issue":"6","key":"606_CR11","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/bib\/bbn035","volume":"9","author":"P Agarwal","year":"2008","unstructured":"Agarwal P, Searls DB. Literature mining in support of drug discovery. Br Bioinform. 2008;9(6):479\u201392. https:\/\/doi.org\/10.1093\/bib\/bbn035 .","journal-title":"Br Bioinform"},{"issue":"2","key":"606_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pcbi.1002375","volume":"8","author":"P Khatri","year":"2012","unstructured":"Khatri P, Sirota M, Butte AJ. Ten years of pathway Analysis\u00a0: current approaches and outstanding challenges. PLoS Comput Biol. 2012;8(2):1\u201310. https:\/\/doi.org\/10.1371\/journal.pcbi.1002375 .","journal-title":"PLoS Comput Biol"},{"key":"606_CR13","unstructured":"UK Cancer incidence for common cancers [hompage on the Internet]. London: Cancer Research UK. Available from: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics-for-the-uk#collapseZero . Accessed 15 Dec 2017."},{"key":"606_CR14","unstructured":"American Cancer Society. Cancer Facts and Figures 2017. Atlanta, Ga: American Cancer Society; 2017."},{"issue":"17","key":"606_CR15","first-page":"2146","volume":"33","author":"X Li","year":"2008","unstructured":"Li X, Du J, Bai B, et al. Inhibitory effects and mechanism of tanshinone IIA on proliferation of rat aortic smooth muscle cells. Zhongguo Zhong Yao Za Zhi. 2008;33(17):2146\u201350.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"606_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780199206650.001.0001","volume-title":"Networks: an introduction","author":"M Newman","year":"2010","unstructured":"Newman M. Networks: an introduction. Oxford: Oxford University press; 2010."},{"issue":"1","key":"606_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.socnet.2004.11.009","volume":"27","author":"M Newman","year":"2005","unstructured":"Newman M. A set of measures of centrality based on betweenness. Soc Netw. 2005;27(1):39\u201354.","journal-title":"Soc Netw"},{"key":"606_CR18","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7150\/jca.17648","volume":"8","author":"M Wang","year":"2017","unstructured":"Wang M, Zhao J, Zhang L, et al. Role of tumor microenvironment in tumorigenesis. J Cancer. 2017;8:761\u201373. https:\/\/doi.org\/10.7150\/jca.17648 .","journal-title":"J Cancer"},{"issue":"66","key":"606_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/genes8020066","volume":"8","author":"Q Luo","year":"2017","unstructured":"Luo Q, Beaver JM, Liu Y, Zhang Z. Dynamics of p53\u00a0: a master decider of cell fate. Genes (Basel). 2017;8(66):1\u201316. https:\/\/doi.org\/10.3390\/genes8020066 .","journal-title":"Genes (Basel)"},{"issue":"1","key":"606_CR20","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3892\/mmr.2011.631","volume":"5","author":"S Chien","year":"2012","unstructured":"Chien S, Kuo S, Chen Y, Chen D. Tanshinone IIA inhibits human hepatocellular carcinoma J5 cell growth by increasing Bax and caspase 3 and decreasing CD31 expression in vivo. Mol Med Rep. 2012;5(1):282\u20136. https:\/\/doi.org\/10.3892\/mmr.2011.631 .","journal-title":"Mol Med Rep"},{"issue":"6","key":"606_CR21","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.3892\/ijmm.2014.1949","volume":"34","author":"CHIN-CHENG SU","year":"2014","unstructured":"Su CC. Tanshinone IIA inhibits human gastric carcinoma AGS cell growth by decreasing BiP, TCTP, mcl - 1 and Bcl - xL and increasing Bax and CHOP protein expression. Int J Mol Med. 2014:1661\u20138. https:\/\/doi.org\/10.3892\/ijmm.2014.1949 .","journal-title":"International Journal of Molecular Medicine"},{"issue":"7","key":"606_CR22","doi-asserted-by":"publisher","first-page":"e42138","DOI":"10.1371\/journal.pone.0042138","volume":"7","author":"F Liu","year":"2012","unstructured":"Liu F, Yu G, Wang G, et al. An NQO1-initiated and p53-independent apoptotic pathway determines the anti-tumor effect of Tanshinone IIA against non-small cell lung Cancer. PLoS One. 2012;7(7):e42138. https:\/\/doi.org\/10.1371\/journal.pone.0042138 .","journal-title":"PLoS One"},{"key":"606_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/582730","volume":"2014","author":"Jiang-Feng Wang","year":"2014","unstructured":"Wang J, Feng J, Han J, Zhang B, Mao W. The molecular mechanisms of Tanshinone IIA on the apoptosis and arrest of human esophageal carcinoma cells. Biomed Res Int. 2014:1\u20139. https:\/\/doi.org\/10.1155\/2014\/582730 .","journal-title":"BioMed Research International"},{"issue":"2","key":"606_CR24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1248\/bpb.b12-00537","volume":"36","author":"S Yun","year":"2013","unstructured":"Yun S, Jeong S, Kim J, et al. Activation of c-Jun N-terminal kinase mediates Tanshinone IIA-induced apoptosis in KBM-5 chronic myeloid leukemia cells. Biol Pharm Bull. 2013;36(2):208\u201314.","journal-title":"Biol Pharm Bull"},{"key":"606_CR25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neulet.2009.12.069","volume":"470","author":"C Tang","year":"2010","unstructured":"Tang C, Xue H, Huang H, Wang X. Tanshinone IIA inhibits constitutive STAT3 activation , suppresses proliferation , and induces apoptosis in rat C6 glioma cells. Neurosci Lett. 2010;470:126\u20139. https:\/\/doi.org\/10.1016\/j.neulet.2009.12.069 .","journal-title":"Neurosci Lett"},{"issue":"7","key":"606_CR26","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1039\/c3mt20272k","volume":"5","author":"P Liu","year":"2013","unstructured":"Liu P, Xu S, Zhang M, et al. Anticancer activity in human multiple myeloma U266 cells: synergy between cryptotanshinone and arsenic trioxide. Metallomics. 2013;5(7):871\u20138. https:\/\/doi.org\/10.1039\/c3mt20272k .","journal-title":"Metallomics"},{"issue":"11","key":"606_CR27","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1248\/bpb.33.1828","volume":"33","author":"S Won","year":"2010","unstructured":"Won S, Lee H, Jeong S, et al. Tanshinone IIA induces mitochondria dependent apoptosis in prostate Cancer cells in association with an inhibition of phosphoinositide 3- kinase \/ AKT pathway. Biol Pharm Bull. 2010;33(11):1828\u201334.","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"606_CR28","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3892\/or.2016.4857","volume":"36","author":"C Su","year":"2016","unstructured":"Su C, Chiu T. Tanshinone IIA decreases the protein expression of EGFR , and IGFR blocking the PI3K \/ Akt \/ mTOR pathway in gastric carcinoma AGS cells both in vitro and in vivo. Oncol Rep. 2016;36(2):1173\u20139. https:\/\/doi.org\/10.3892\/or.2016.4857 .","journal-title":"Oncol Rep"},{"issue":"5","key":"606_CR29","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1158\/1940-6207.CAPR-11-0551","volume":"5","author":"W Chen","year":"2012","unstructured":"Chen W, Liu L, Luo Y, et al. Cryptotanshinone activates p38\/JNK and inhibits Erk1\/2 leading to caspase-independent cell death in tumor cells. Cancer Prev Res. 2012;5(5):778\u201387. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-11-0551 .","journal-title":"Cancer Prev Res"},{"issue":"8","key":"606_CR30","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1021\/acs.chemrestox.5b00150","volume":"28","author":"C Chang","year":"2015","unstructured":"Chang C, Kuan C, Lin J, Lai J, Ho T. Tanshinone IIA facilitates TRAIL sensitization by up-regulating DR5 through the ROS-JNK-CHOP signaling Axis in human ovarian carcinoma cell lines. Chem Res Toxicol. 2015;28(8):1574\u201383. https:\/\/doi.org\/10.1021\/acs.chemrestox.5b00150 .","journal-title":"Chem Res Toxicol"},{"issue":"2","key":"606_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0955-0674(98)80143-9","volume":"10","author":"Y Ip","year":"1998","unstructured":"Ip Y, Davis R. Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development. Curr Opin Cell Biol. 1998;10(2):205\u201319.","journal-title":"Curr Opin Cell Biol"},{"key":"606_CR32","first-page":"1","volume":"2013","author":"Ji Hoon Jung","year":"2013","unstructured":"Jung JH, Kwon T, Jeong S, et al. Apoptosis induced by Tanshinone IIA and Cryptotanshinone is mediated by distinct JAK \/ STAT3 \/ 5 and SHP1 \/ 2 signaling in chronic myeloid leukemia K562 cells. Evid Based Complement Altern Med. 2013;2013:1\u201310. Article ID 805639, http:\/\/dx.doi.org\/10.1155\/2013\/805639 .","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"issue":"6","key":"606_CR33","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3892\/ijmm","volume":"22","author":"C Su","year":"2008","unstructured":"Su C, Lin Y. Tanshinone IIA down-regulates the protein expression of ErbB-2 and up-regulates TNF- \u03b1 in colon cancer cells in vitro and in vivo. Int J Mol Med. 2008;22(6):847\u201351. https:\/\/doi.org\/10.3892\/ijmm .","journal-title":"Int J Mol Med"},{"key":"606_CR34","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1055\/s-2008-1081299","volume":"74","author":"O Paper","year":"2008","unstructured":"Paper O. Growth inhibition and apoptosis induction by Tanshinone IIA in human Colon adenocarcinoma cells. Planta Med. 2008;74:1357\u201362. https:\/\/doi.org\/10.1055\/s-2008-1081299 .","journal-title":"Planta Med"},{"issue":"3","key":"606_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/abbs\/gmu129","volume":"47","author":"Z Niu","year":"2015","unstructured":"Niu Z, Liu H, Zhou M. Knockdown of c-Myc inhibits cell proliferation by negatively regulating the Cdk\/Rb\/E2F pathway in nasopharyngeal carcinoma cells. Acta Biochim Biophys Sin. 2015;47(3):183\u201391.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"4","key":"606_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/pcan.2013.38","volume":"16","author":"SC Chiu","year":"2013","unstructured":"Chiu SC, Huang SY, Chen SP, Su CC, Chiu TL, Pang CY. Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo. Prostate Cancer Prostatic Dis. 2013;16(4):315\u201322. https:\/\/doi.org\/10.1038\/pcan.2013.38 .","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"7015","key":"606_CR37","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nature03097","volume":"432","author":"Michael B. Kastan","year":"2004","unstructured":"Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature. 2004;432:316\u201323.","journal-title":"Nature"},{"issue":"2","key":"606_CR38","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.3390\/ijms15023145","volume":"15","author":"S Shimizu","year":"2014","unstructured":"Shimizu S, Yoshida T, Tsujioka M, Arakawa S. Autophagic cell death and Cancer. Int J Mol Sci. 2014;15(2):3145\u201353. https:\/\/doi.org\/10.3390\/ijms15023145 .","journal-title":"Int J Mol Sci"},{"key":"606_CR39","unstructured":"WHO. WHO Cancer Fact sheet. http:\/\/www.who.int\/mediacentre\/factsheets\/fs297\/en\/ . Accessed 04 Sept 2017."},{"issue":"10","key":"606_CR40","first-page":"7","volume":"25","author":"A Kumar","year":"2018","unstructured":"Kumar A, Soares HP, Balducci L, Djulbegovic B. Treatment tolerance and efficacy in geriatric Oncology\u00a0: a systematic review of phase III randomized trials conducted by five National Cancer Institute \u2013 sponsored cooperative groups. J Clin Oncol. 2018;25(10):7\u20139.","journal-title":"J Clin Oncol"},{"issue":"January","key":"606_CR41","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/02841869209088904","volume":"31","author":"AL Harris","year":"1992","unstructured":"Harris AL, Hochhauser D. Mechanisms of multidrug resistance in Cancer treatment. Acta Oncol (Madr). 1992;31(January):205\u201313.","journal-title":"Acta Oncol (Madr)"},{"key":"606_CR42","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.molonc.2014.07.011","volume":"8","author":"S Kelderman","year":"2014","unstructured":"Kelderman S, Schumacher TNM, Haanen JBAG. Acquired and intrinsic resistance in cancer immunotherapy. Mol Oncol. 2014;8:1132\u20139.","journal-title":"Mol Oncol"},{"issue":"9","key":"606_CR43","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1002\/jcb.24553","volume":"114","author":"C Lin","year":"2013","unstructured":"Lin C, Wang L, Wang H, Yang L, Guo H, Wang X. Tanshinone IIA inhibits breast Cancer stem cells growth in vitro and in vivo through attenuation of IL-6\/STAT3\/NF-kB signaling pathways. J Cell Biochem. 2013;114(9):2061\u201370. https:\/\/doi.org\/10.1002\/jcb.24553 .","journal-title":"J Cell Biochem"},{"key":"606_CR44","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/35019019","volume":"406","author":"R Albert","year":"2000","unstructured":"Albert R, Jeong H, Barabasi A. Error and attack tolerance of complex networks. Nature. 2000;406:378\u201382.","journal-title":"Nature"},{"key":"606_CR45","unstructured":"Nature.com, Cancer microenvironment. https:\/\/www.nature.com\/subjects\/cancer-microenvironment . Accessed 18 Dec 2017."},{"issue":"9","key":"606_CR46","doi-asserted-by":"publisher","first-page":"5900","DOI":"10.1167\/iovs.14-14008","volume":"55","author":"S Rhiu","year":"2017","unstructured":"Rhiu S, Chae MK, Lee EJ, Lee JB, Yoon JS. Effect of Tanshinone IIA in an in vitro model of graves \u2019 Orbitopathy. IOVS. 2017;55(9):5900\u201310. https:\/\/doi.org\/10.1167\/iovs.14-14008 .","journal-title":"IOVS"},{"issue":"11","key":"606_CR47","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1038\/aps.2009.139","volume":"30","author":"Y Shan","year":"2009","unstructured":"Shan Y, Shen X, Xie Y, et al. Inhibitory effects of tanshinone II-A on invasion and metastasis of human colon carcinoma cells. Acta Pharmacol Sin. 2009;30(11):1537\u201342. https:\/\/doi.org\/10.1038\/aps.2009.139 .","journal-title":"Acta Pharmacol Sin"},{"key":"606_CR48","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.biosystems.2005.05.014","volume":"83","author":"JJ Hornberg","year":"2006","unstructured":"Hornberg JJ, Bruggeman FJ, Westerhoff HV, Lankelma J. Cancer\u00a0: a systems biology disease. Biosystems. 2006;83:81\u201390. https:\/\/doi.org\/10.1016\/j.biosystems.2005.05.014 .","journal-title":"Biosystems"},{"key":"606_CR49","unstructured":"Creech M, Kuchinsky A, Vailaya A. Agilent Literature Search Software. 2014."},{"key":"606_CR50","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/nprot.2013.092","volume":"8","author":"H Mi","year":"2013","unstructured":"Mi H, Muruganujan A, Casagrande JT, Thomas PD. Large-scale gene function analysis with the PANTHER classification system. Nat Protoc. 2013;8:1551\u201366.","journal-title":"Nat Protoc"},{"issue":"10","key":"606_CR51","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3724\/SP.J.1009.2015.00751","volume":"13","author":"C Shao-jun","year":"2015","unstructured":"Shao-jun C. Drug-target networks for Tanshinone IIA identified by data mining. Chin J Nat Med. 2015;13(10):751\u20139. https:\/\/doi.org\/10.3724\/SP.J.1009.2015.00751 .","journal-title":"Chin J Nat Med"}],"container-title":["BMC Systems Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12918-018-0606-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12918-018-0606-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12918-018-0606-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T07:20:03Z","timestamp":1605338403000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsystbiol.biomedcentral.com\/articles\/10.1186\/s12918-018-0606-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,29]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["606"],"URL":"https:\/\/doi.org\/10.1186\/s12918-018-0606-6","relation":{},"ISSN":["1752-0509"],"issn-type":[{"value":"1752-0509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,29]]},"assertion":[{"value":"30 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. The manuscript does not report on or involve the use of any animal or human data or tissue.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. The manuscript does not contain data from any individual person.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"90"}}